These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3843558)

  • 1. Immunostimulation with an allied mycobacterium and DDS chemotherapy in lepromatous leprosy.
    Chaudhury S; Hazra S; Chatterjee BC; Dey SK; Chaudhury SN; Das P
    Indian J Dermatol; 1985 Oct; 30(4):3-10. PubMed ID: 3843558
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of simultaneous administration of interferon-gamma and chemotherapy against Mycobacterium leprae in experimental infection in nude mice.
    Banerjee DK; McDermott-Lancaster RD
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):690-6. PubMed ID: 2126271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present evaluation of hansenian treatment by association of chemotherapy and immunostimulation (author's transl)].
    Saint-Andre P; Louvet M; Giraudeau P; Discamps G; Schlecht B
    Med Trop (Mars); 1978; 38(3):331-49. PubMed ID: 723581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 9. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
    Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment.
    Melsom R; Harboe M; Naafs B
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
    Almeida JG; Chacko CJ; Christian M
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal reaction to dapsone during treatment of leprosy.
    Frey HM; Gershon AA; Borkowsky W; Bullock WE
    Ann Intern Med; 1981 Jun; 94(6):777-9. PubMed ID: 7235421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy.
    Pearson JM; Pettit JH
    Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.